Aug
1
Apr
18
New FDA Guidance for Long-standing Deferral; HIV Changes
The Food and Drug Administration issued new guidance on blood donations, removing some long-standing deferrals. In addition to this, the FDA is also considering moving towards an individualized risk-based approach when deciding donor eligibility. These changes are related to HIV medications and those at risk for contracting HIV.
This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.
Recommended Content:
Update: Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2012–2020
Influenza Surveillance Trends and Influenza Vaccine Effectiveness Among Department of Defense Beneficiaries During the 2019–2020 Influenza Season
Influenza Outbreak During Exercise Talisman Sabre, Queensland, Australia, July 2019
Exertional Rhabdomyolysis and Sickle Cell Trait Status in the U.S. Air Force, Jan. 2009–Dec. 2018
Update: Cold Weather Injuries, Active and Reserve Components, U.S. Armed Forces, July 2015–June 2020
Health.mil News
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.